SAFETY AND PHARMACOKINETICS OF MIFENTIDINE AFTER INCREASING ORAL DOSES IN HEALTHY-SUBJECTS

被引:1
|
作者
IMBIMBO, BP
SEIBERLING, M
PEUCKERT, U
HOEXTER, G
MAIERLENZ, H
VIDI, A
DANIOTTI, S
机构
[1] BOEHRINGER INGELHEIM,MILAN,ITALY
[2] INST CLIN PHARMACOL,FREIBURG,FED REP GER
关键词
D O I
10.1007/BF00637606
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:673 / 676
页数:4
相关论文
共 50 条
  • [21] COMPARATIVE PHARMACOKINETICS OF MIDAZOLAM AND LOPRAZOLAM IN HEALTHY-SUBJECTS AFTER ORAL-ADMINISTRATION
    JOCHEMSEN, R
    VANRIJN, PA
    HAZELZET, TGM
    VANBOXTEL, CJ
    BREIMER, DD
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (01) : 53 - 61
  • [22] Pharmacokinetics and safety of sitafloxacin after single oral doses in healthy volunteers
    Wu, Guolan
    Wu, Lihua
    Hu, Xingjiang
    Zhou, Huili
    Liu, Jian
    Zhu, Meixiang
    Zheng, Yunliang
    Zhai, You
    Shentu, Jianzhong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (12) : 1037 - 1044
  • [23] ENPROFYLLINE KINETICS IN HEALTHY-SUBJECTS AFTER SINGLE DOSES
    BORGA, O
    ANDERSSON, KE
    EDHOLM, LE
    FAGERSTROM, PO
    LUNELL, E
    PERSSON, CG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) : 799 - 804
  • [24] SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE IN HEALTHY-SUBJECTS AFTER SINGLE AND REPEATED ORAL DOSES
    ALAHURULA, V
    MYLLYLA, VV
    ARVELA, P
    KARKI, NT
    HOKKANEN, E
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1980, : 7 - 9
  • [25] Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects
    Kroesser, S.
    Tillner, J.
    Fluck, M.
    Ungethuem, W.
    Wolna, P.
    Kovar, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (05) : 271 - 280
  • [26] PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN HEALTHY-SUBJECTS FOLLOWING SINGLE AND MULTIPLE DOSES
    FOSTER, RT
    JAMALI, F
    RUSSELL, AS
    ALBALLA, SR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) : 70 - 73
  • [27] Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects
    Erhardtsen, E
    Nilsson, P
    Johannessen, M
    Thomsen, MS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08): : 880 - 885
  • [28] Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
    Yan, Jing-He
    Bifano, Marc
    Olsen, Steven
    Smith, Robert A.
    Zhang, Duxi
    Grasela, Dennis M.
    LaCreta, Frank
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1250 - 1258
  • [29] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FALDAPREVIR AFTER SINGLE RISING DOSES IN HEALTHY SUBJECTS
    Sennewald, R.
    Narjes, H.
    Yong, C.
    Nehmiz, G.
    Huang, F.
    Stern, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S69 - S69
  • [30] Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects
    Iwamoto, M.
    Wenning, L. A.
    Petry, A. S.
    Laethem, M.
    De Smet, M.
    Kost, J. T.
    Merschman, S. A.
    Strohmaier, K. M.
    Ramael, S.
    Lasseter, K. C.
    Stone, J. A.
    Gottesdiener, K. M.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 293 - 299